Production (Stage)
Shanrong Biotechnology Corp.
SRBT
$0.28
-$0.188-40.17%
OTC PK
| 12/31/2009 | 09/30/2009 | ||||
|---|---|---|---|---|---|
| Revenue | -13.62% | -81.49% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -13.62% | -81.49% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -13.62% | -81.49% | |||
| SG&A Expenses | 3,887.08% | -110.32% | |||
| Depreciation & Amortization | -89.99% | 898.88% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 21,938.50% | -101.78% | |||
| Operating Income | -2,827.59% | 139.90% | |||
| Income Before Tax | -2,308.46% | 141.19% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -2,308.46% | 141.19% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -2,308.46% | 141.19% | |||
| EBIT | -2,827.59% | 139.90% | |||
| EBITDA | -2,664.81% | 143.39% | |||
| EPS Basic | -2,231.28% | 141.11% | |||
| Normalized Basic EPS | -2,231.35% | 141.10% | |||
| EPS Diluted | -2,278.52% | 141.11% | |||
| Normalized Diluted EPS | -2,231.35% | 141.10% | |||
| Average Basic Shares Outstanding | 3.58% | 0.25% | |||
| Average Diluted Shares Outstanding | 3.58% | 0.25% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||